Short answer: there’s no simple yes — and any page that gives you one is guessing. Whether Lynkuet is covered by Medicare depends entirely on your specific Medicare Part D plan or your Medicare Advantage drug plan, and whether that plan lists Lynkuet on its formulary. Original Medicare — Parts A and B — generally isn’t the coverage path for a take-home menopause pill like this, so Part D is what matters. Two things most pages bury: the commercial $25 copay card won’t work for you, and a brand-new drug takes time for plans to add — so even if it’s covered, you’ll likely face prior authorization.
Here’s the fast version, so you don’t have to scroll:
| Your question | The fast answer | What to do next |
|---|---|---|
| Is Lynkuet covered by Medicare? | Maybe — but only through a Part D or Medicare Advantage drug plan that lists it. | Check your plan’s drug list (formulary). |
| Is it covered by Original Medicare (Part B)? | Not the path — Part B covers only certain clinic-given drugs, not take-home pills like Lynkuet. | Look at your Part D coverage instead. |
| Can I use the $25 Lynkuet card? | No — not if you’re on Medicare or any government plan. | Use the Medicare-friendly savings routes below. |
| Will I need prior authorization? | Likely. Several 2026 payer policies already require it. | Get your prescriber ready before you fill it. |
| What does it cost without coverage? | About $625 a month (Bayer’s list price). | See the cost section before you pay cash. |
| What if my plan denies it? | You have exception, appeal, assistance, and alternative options. | Use our denial-response steps below. |
Not sure where your plan lands?
Answer a few quick questions and get a plan-check script, a prior-authorization checklist, and your most likely next step to take to your prescriber or pharmacist.
Check my Lynkuet Medicare coverage path →Medicare may cover Lynkuet, but only through a Medicare Part D prescription drug plan or a Medicare Advantage plan that includes drug coverage and lists Lynkuet on its formulary. Original Medicare (Parts A and B) does not cover most take-home prescription drugs, so it is not the coverage path for Lynkuet. Because every Part D plan sets its own formulary, tiers, and rules, coverage is plan-specific — there is no single yes-or-no answer that applies to everyone.
First, what Lynkuet is, since it matters here. Lynkuet (generic name elinzanetant) is a non-hormonal prescription pill for moderate-to-severe hot flashes and night sweats during menopause — doctors call those vasomotor symptoms (VMS). It’s the first dual NK1/NK3 receptor antagonist, meaning it calms the brain signals that trigger hot flashes, without using hormones. Lynkuet is not a hormone. It’s a self-administered, take-home pill — and that classification is exactly why Part D is the right coverage bucket.
| Type of Medicare | What it means for Lynkuet |
|---|---|
| Original Medicare — Part A | Hospital coverage. Not the route for a menopause pill. |
| Original Medicare — Part B | Covers only a limited set of outpatient drugs, mostly ones given in a clinic. A take-home pill like Lynkuet isn’t covered here. |
| Medicare Part D | The main coverage path. Prescription drug coverage you buy as a standalone plan. Coverage depends on your plan’s formulary. |
| Medicare Advantage (with drug coverage) | Often called MA-PD. May cover Lynkuet if its built-in drug formulary lists it. |
| Medigap (Supplement) | Helps with Part A/B costs. Does not replace Part D drug coverage. |
| Medicaid / dual eligibility | State- and plan-specific. Don’t assume the commercial savings card applies — it doesn’t. |
The only reliable way to answer “is Lynkuet covered by Medicare for me” is to check your exact Part D or Medicare Advantage drug formulary — not a general Medicare search. You need to confirm four things: whether Lynkuet is listed, what cost tier it’s on, whether it needs prior authorization or step therapy, and what you’d pay at your pharmacy in your current coverage stage. This takes about two minutes once you know where to look.
Here’s the exact process. Do it in this order:
When you call your plan, read them this:
“I’m checking coverage for Lynkuet — generic name elinzanetant — for menopause hot flashes. Is it on my formulary? What tier is it? Does it need prior authorization, step therapy, or have a quantity limit? And what would I pay at my current coverage stage at a preferred pharmacy?”
That one question gets you most of what you need.
Your Lynkuet cost with Medicare depends on whether your plan covers it, your tier, your deductible, your coinsurance, and whether you qualify for Extra Help. Bayer’s list price is about $625 per month if you’re uninsured or your plan doesn’t cover it. If your plan does cover it, a key 2026 rule works in your favor: once your out-of-pocket drug spending hits $2,100, you pay $0 for covered drugs for the rest of the year.
Bayer states it plainly: if you’re uninsured or Lynkuet isn’t covered, it costs $625 a month (wholesale list price, through Bayer’s BlinkRx pharmacy). Cash and discount-card prices vary. As of , GoodRx showed Lynkuet starting around $639 and SingleCare listed a normal cash price near $1,000 with a coupon price around $613. Treat those as data points, not promises — confirm with your pharmacy before you fill.
In the standard 2026 Part D design, a covered drug moves through stages:
And if a big early bill is the problem, ask about the Medicare Prescription Payment Plan — it’s free and voluntary, and it lets you spread your out-of-pocket drug costs into smaller monthly payments instead of paying it all at once at the counter. It doesn’t lower your total; it just makes it manageable.
Quick cost cheat sheet:
| Your situation | What to expect |
|---|---|
| Covered, deductible not met yet | Higher cost early in the year (up to your deductible). |
| Covered, deductible met | About 25% coinsurance (or your plan’s copay) until you hit the $2,100 cap, then $0. |
| Covered, but PA required | The first claim may reject until your prescriber sends documentation. |
| Not on your formulary | You’ll need an exception, appeal, alternative, or a cash/assistance route. |
| You qualify for Extra Help | Your cost may drop to no more than $12.65 per covered brand-name drug. |
| You try a commercial coupon | It won’t work — Medicare is excluded (see next section). |
► See what you’d really pay
Get a first-month and yearly out-of-pocket estimate based on your plan’s deductible and the 2026 cap.
Estimate my Lynkuet cost by plan →No. The Lynkuet “$25 a month” copay savings card — offered through Bayer’s BlinkRx program for commercially insured patients — is not available to anyone enrolled in Medicare, Medicaid, TRICARE, VA, or other government health programs. If you’re on Medicare, your real path is your Part D coverage plus the Medicare-friendly assistance options below, not the commercial coupon.
You’ve probably seen the headline: “pay as little as $25 a month.” That offer is real — but it’s for people with commercial (private or employer) insurance, and Bayer/BlinkRx terms specifically exclude Medicare, Medicaid, TRICARE, VA, and Department of Defense coverage. Why? It’s not Bayer being stingy — it’s legal risk. Federal anti-kickback rules put drugmakers on the hook if coupons get used for drugs paid by programs like Medicare.
One more nuance: Bayer’s BlinkRx setup also has an “outside-insurance” affordability route. But if you have government coverage, any amount you pay that way won’t count toward your Medicare deductible or your $2,100 out-of-pocket cap. So it’s not a shortcut around your Part D math. Ask your pharmacist to explain which programs you actually qualify for before you choose. For the full savings card guide, see Lynkuet Savings Card: Who Qualifies?
Even though the commercial copay card is off the table, Medicare beneficiaries have real ways to lower the cost of Lynkuet. The main ones are Medicare’s Extra Help program for lower incomes, the Bayer US Patient Assistance Foundation (which can provide Lynkuet at no cost to patients it approves), a formulary exception or appeal through your prescriber, and the Medicare Prescription Payment Plan to spread costs across the year.
| Savings route | Works on Medicare? | The details |
|---|---|---|
| Lynkuet $25 commercial copay card | ✗ No | Commercial insurance only; excludes Medicare and government plans. |
| Extra Help (Low-Income Subsidy) | ✓ Yes, if you qualify | For people with income up to 150% of the federal poverty level who also meet resource limits. In 2026, qualifying members pay no more than $12.65 for a covered brand-name drug like Lynkuet, with $0 deductible. Apply at ssa.gov or 1-800-772-1213. |
| Bayer US Patient Assistance Foundation | ✓ Yes, if eligible | Can provide Lynkuet free to patients it approves. Generally eligible if you live in the U.S., meet the income limit (around 300% of the federal poverty level), and are either uninsured or your plan doesn’t cover Lynkuet. Being on Medicare Part D doesn’t automatically rule you out. Check patientassistance.bayer.us or 1-866-228-7723. |
| Formulary exception / prior authorization | ✓ Yes | Your prescriber asks your plan to cover Lynkuet (or waive a restriction) with a medical reason. |
| Appeal a denial | ✓ Yes | If your plan says no, you have formal appeal rights. |
| Medicare Prescription Payment Plan | ✓ Yes | Doesn’t lower the total, but spreads your out-of-pocket cost into monthly payments so you’re not hit with a big bill at once. |
The one most people miss is the Bayer US Patient Assistance Foundation. Many assistance programs slam the door on anyone with government insurance — but Bayer’s doesn’t automatically rule out Medicare Part D members. Honest caveats: eligibility isn’t guaranteed, if your income is under 150% of poverty you’ll need to be turned down for Extra Help first, and any medication you get this way can’t be billed to Medicare or counted toward your out-of-pocket. But for the right person, it can be the difference between $0 and $625 a month. It’s worth ten minutes to check.
► Not sure which option fits your situation?
A 60-second matching quiz maps your options based on your coverage, income, and what you’ve already tried. You’ll know your next step before you call anyone.
Get my personalized menopause-care action plan →A denial isn’t always the end. Depending on why your plan said no, your next move may be a prior authorization, a formulary exception, a formal appeal, a switch to a covered alternative, an Extra Help review, or a manufacturer-assistance application. The right step depends on the exact reason for the denial, so the first thing to do is find out why.
Don’t panic, and don’t just hand over $625. Ask the plan or pharmacy why it was denied, then match the reason to the move:
| Why it was denied | What it means | Your next step |
|---|---|---|
| Not on the formulary | Your plan doesn’t list Lynkuet | Ask for a formulary exception or discuss alternatives. |
| Prior authorization required | The plan needs clinical paperwork | Ask your prescriber to submit the PA. |
| Step therapy required | You must try another drug first | Ask what counts as a trial, failure, or contraindication. |
| Quantity limit | The plan caps the amount per fill | Confirm your dose matches the covered limit (two capsules daily). |
| Non-preferred pharmacy | Your pharmacy is out of network | Check your plan’s preferred or mail-order pharmacy. |
| Deductible not met | It’s covered, just expensive early in the year | Ask your cost after the deductible and under the 2026 stages. |
| Coupon rejected | Medicare is excluded from the card | Stop using the commercial coupon; use the assistance routes above. |
If hormone therapy is the sticking point: It’s worth knowing that hormone therapy is still the most effective treatment for hot flashes for women who can safely use it. But some women can’t — those with conditions like certain hormone-sensitive cancers, blood clots, stroke, or heart attack — which is one reason non-hormonal options like Lynkuet exist. Your prescriber is the right person to weigh hormonal versus non-hormonal options.
If you’d rather get specialist help instead of navigating this alone: Some readers, after learning Medicare may not cover Lynkuet, decide they want to talk options with a menopause specialist and are comfortable paying out of pocket. A telehealth clinic like Midi Health focuses specifically on menopause and prescribes both hormonal and non-hormonal treatments.
Want specialist guidance on non-hormonal menopause options?
Midi Health focuses on menopause care — including non-hormonal options — and can see Medicare patients on a self-pay basis. Self-pay only; not covered by Medicare.
Learn about Midi’s menopause care →Midi is one of the providers we partner with — The HRT Index may earn a commission if you sign up, at no extra cost to you. We mention it here only because it genuinely fits this specific reader.
► Denied, and not sure what to do?
Match your denial reason to the exact words to use and the document to request.
See my next step after a Lynkuet denial →Coverage is only half the decision. Lynkuet’s FDA label calls for a liver blood test before you start and again at about 3 months, says it shouldn’t be used during pregnancy, and flags caution for people with a history of seizures. It’s also not recommended for people with moderate-to-severe liver problems or end-stage kidney disease, and a few common medications (and grapefruit) change how it’s dosed. These are quick things to settle before you invest energy fighting for coverage.
Bring these questions to your prescriber:
A few facts to ground the conversation. Lynkuet is taken as two 60 mg capsules (120 mg total) once daily at bedtime, with or without food. The label calls for baseline liver labs (and a recheck at about three months). And here’s a genuine point in Lynkuet’s favor: it does not carry the liver “boxed warning” that the FDA added to Veozah. Liver monitoring is still required — but Lynkuet’s label doesn’t include that boxed warning.
Coverage shouldn’t be your only deciding factor. Lynkuet, Veozah, and hormone therapy differ in how they work, what they’re approved for, and what monitoring they need — and their Medicare coverage all depends on your specific plan. The best choice balances medical fit and affordability together, with your prescriber.
| Option | Hormonal? | Mainly used for | Coverage notes |
|---|---|---|---|
| Lynkuet (elinzanetant) | No | Moderate-to-severe menopause hot flashes / night sweats | New brand drug; plan-specific Part D coverage; often prior authorization and a quantity limit. No liver boxed warning, but liver labs still required. |
| Veozah (fezolinetant) | No | Moderate-to-severe VMS | Brand drug; carries a liver boxed warning with more intensive monitoring language; coverage may also require prior authorization or step therapy. |
| Hormone therapy | Yes | Often the most effective for VMS in suitable candidates | Coverage varies by product, form, and brand vs. generic; generics are usually better covered and cheaper. |
If you’re still weighing which treatment to ask for, see our deeper comparison of Veozah vs. Lynkuet, or the full breakdown at Does Insurance Cover Lynkuet?
The highest-friction situations are predictable: people whose plans don’t list Lynkuet yet, people facing prior authorization or step therapy, people who saw the $25 card before realizing Medicare is excluded, and people early in the year before they’ve met their deductible. If you’re in one of these groups, you need a plan-specific answer — not a generic price estimate.
Find yourself here:
“Is Lynkuet covered by Medicare” feels like it should have a yes-or-no answer, but it doesn’t — and that’s not your fault. The confusion comes from four different “prices” getting mixed together, a brand-new drug that plans are still adding, and a savings card that quietly excludes the exact people asking. Once you separate coupon, cash, commercial, and Part D, the picture gets clear fast.
So here’s the untangling, one more time, in plain terms: the $25 card is for private insurance only. The discount-card price (around $600–$1,000) is for paying cash. Commercial insurance is what employer or private plans negotiate. And Medicare Part D is your plan’s own price, set by its formulary and tier. If you’re on Medicare, only that last one — plus Extra Help and the Bayer assistance foundation — applies to you. That’s the whole knot, undone.
► Still not sure whether Lynkuet is the right next conversation with your clinician?
Take our free 60-second matching quiz and get a personalized action plan.
Take the free matching quiz →We put this page together by separating four things that often get blended on other sites: medical facts, Medicare rules, manufacturer assistance terms, and real-world coverage signals. Here’s exactly what we checked, and where.
| What we verified | Source | What it says | Checked |
|---|---|---|---|
| Lynkuet’s identity, approval, and dose | FDA Drug Trials Snapshots; FDA prescribing information | Non-hormonal NK1/NK3 antagonist; FDA-approved Oct 24, 2025; two 60 mg capsules once daily at bedtime | |
| Liver labs and key precautions | FDA prescribing information (DailyMed) | Baseline + 3-month liver labs; avoid grapefruit/strong CYP3A4 inhibitors; reduce to 60 mg with moderate inhibitors; not recommended in moderate-to-severe hepatic impairment or end-stage renal disease; contraindicated in pregnancy | |
| No boxed warning (vs. Veozah) | FDA labels (Lynkuet, Veozah) | Lynkuet has no boxed warning; Veozah carries a liver boxed warning | |
| List price | Bayer’s Lynkuet site; trade press | $625 per month if uninsured/not covered | |
| Cash / discount prices | GoodRx; SingleCare | GoodRx from ~$639; SingleCare ~$1,000 cash / ~$613 with coupon | |
| The $25 card excludes Medicare | Bayer/BlinkRx program terms | Commercial insurance only; Medicare/Medicaid/government programs excluded | |
| Bayer Patient Assistance Foundation | Bayer foundation materials | Free drug for approved patients; ~300% FPL income limit; Medicare Part D members not auto-excluded | |
| 2026 Medicare figures | Medicare.gov / CMS-aligned sources | $615 maximum deductible; $2,100 out-of-pocket cap; Extra Help brand copay no more than $12.65 | |
| Real prior-authorization rules | Oscar Health (PG281), CVS Caremark, Western Health Advantage | PA, quantity limits, and prior-hormone-therapy requirements for Lynkuet | |
| Midi’s Medicare status | Midi Health help center | Self-pay only for Medicare patients; not Medicare-enrolled; can’t treat Medicaid/Medi-Cal |
Our update schedule:we re-check Lynkuet’s price and assistance terms monthly, plan-coverage rules quarterly and at each Medicare enrollment cycle, and the FDA label whenever it changes.
Coverage for a brand-new drug like Lynkuet is genuinely confusing, but your path is simple once you cut through the noise: check your own Part D plan, skip the $25 card (it won’t work for you), and line up the Medicare-friendly savings routes — Extra Help, the Bayer assistance foundation, or a prior authorization — before you pay a cent. You have more options than the pharmacy counter makes it seem.
Need more context on coverage? See our full guide: Does Insurance Cover Lynkuet? 2026 Coverage, Cost & Copay · Lynkuet Prior Authorization (2026) · Lynkuet Savings Card: Who Qualifies?
Still not sure whether Lynkuet, hormone therapy, or another menopause-care path is the right next conversation with your clinician?
Take our free 60-second matching quiz →